Navigation Links
OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals
Date:11/23/2012

ability to treat disease states. MANF has been shown to stop disease progression in animal models of Parkinson's disease, protect the heart in instances of chemically induced toxicity, and in this work, protect against ischemia-reperfusion heart injury. Taken together these studies delineate the vast potential of MANF as a therapeutic, providing Amarantus with the requisite empirical evidence needed to propel this drug candidate into advanced developmental stages and clinical trials."

Ischemia-reperfusion injury within the context of acute ischemic heart disease (myocardial infarction) is one of the major causes of long-term disability following cardiovascular events. Treatments for ischemia reperfusion emain a key unmet medical needs in treating cardiovascular events, as there are currently no approved therapies that address this critical biological pathway that is responsible for significant side effects. The market opportunity for a drug that significantly reduces infarct zone size following cardiovascular events exceeds $1 billion annually.

About OneMedPlace

Through news services, radio interviews, video production, and research, OneMedPlace specializes in delivering information to investors covering nanocap, microcap and private emerging growth companies in the hottest areas of life sciences. Established in 2008, OneMedForum is the conference component of OneMedPlace, a biannual event showcasing the best ideas and innovations from around the world. The 3-day conference features over 1,000 attendees, consisting of private investors, venture capitalists, angel networks and private equity, as well as strategic partners, licensees, advisors and research analysts. The 6th Annual OneMedForum takes place January 7th-9th , 2013 in San Francisco.

About Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a develo
'/>"/>

SOURCE Amarantus BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
2. HCCS Releases ICD-10 Countdown Clock With Integrated CMS Twitter Tweets
3. eCareSoft Releases eCS Cirrus™
4. AtheroNova Releases 2011 Financial Results
5. Atlanta LASIK Surgeon Dr. Ashraf Releases YouTube Videos Featuring Patient Testimonials and Discussion of Common Eye Treatments
6. ILVO-T&V Belgium Releases Validation Report of the Charm Sciences Beta-lactam and Tetracycline 2-minute Test for Raw Commingled Milk
7. ISPE Releases New Guidance for Designing and Constructing Packaging, Labeling and Warehousing Facilities
8. Happtique Releases Draft App Certification Program Standards For Public Comment
9. ClearCanvas Releases New Workstation Products Designed to Assist With Image Sharing
10. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
11. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 BioPlus Specialty ... pharmacies, announces the promotion of Nick Maroulis, Pharm.D. to ... Pharmacy Services. , In this position, Dr. Maroulis ... also managing the directors of our multi-site pharmacies as ... since 1997 and during that time he has served ...
(Date:12/19/2014)... , Dec. 19, 2014  Roche (SIX: RO, ... Bina Technologies, Inc. (Bina), a privately held company ... , USA. Bina provides a big data platform ... sequencing (NGS) data. Bina,s proprietary on-market Genomic Management ... academic researchers to perform fast and scalable analyses ...
(Date:12/19/2014)... 2014 Decision Resources Group finds that the ... 12 percent compound annual growth rate through 2023. This ... and the increasing adoption of dental implants. Growing aesthetic ... also spur demand for dental biomaterials because they can ... treatments. Other key findings from Decision Resources ...
(Date:12/19/2014)... Altamonte Springs, FL (PRWEB) December 18, 2014 ... one of the nation’s leading specialty pharmacies, has ... who serve as clinical pharmacy consultants for prescriber ... disease therapy expertise. , “We have a ... disease therapies. For example, those specializing in hepatitis ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3
... Institutional Private Placement -, - $10 Million Principal Amount of Debt ... ... Stock -, DALLAS, Nov. 8 Access Pharmaceuticals, ... a $19.5 million recapitalization. The Company has entered,into agreements with institutional ...
... announced,the addition of Mr. Robert A. Ingram as Special ... and the hiring of Mr. Marty Glick as Executive ... Pharmaceuticals at GlaxoSmithKline (plc),and previously served as Chief Executive ... Glaxo Wellcome. Mr. Ingram,is Chairman of the Board of ...
... --,Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT),announced ... were $6,214,712,an increase of 567% over $930,442 in the ... third quarter of 2007 were $2,957,972 an increase of,226% ... These significant,increases are due to the growth of Kiwa,s ...
Cached Biology Technology:Access Pharmaceuticals Announces $19.5 Million Recapitalization 2Access Pharmaceuticals Announces $19.5 Million Recapitalization 3Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 3Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 4Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 5Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 6Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 7Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 8Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 9
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... ARTICLE #1 FOR IMMEDIATE RELEASE Lead leaching ... Science & Technology Scientists in Virginia are ... (PVC) plastic pipes may be more susceptible to leaching ... types of piping especially when PVC systems include ...
... June 2, 2008 UT Southwestern Medical Center ... pancreatic beta cells can regenerate after being induced to ... future insights into improved treatments of diabetes, which affects ... mouse, mimics what occurs in humans with type 1 ...
... already imperiled sturgeons, more caviar will be exported from ... a result of unacceptably permissive new trade quotas announced ... Species (CITES). Most sturgeon species are endangered and some, ... will further damage this ancient fish,s chance of recovery ...
Cached Biology News:American Chemical Society's Weekly PressPac -- May 28, 2008 2American Chemical Society's Weekly PressPac -- May 28, 2008 3American Chemical Society's Weekly PressPac -- May 28, 2008 4American Chemical Society's Weekly PressPac -- May 28, 2008 5American Chemical Society's Weekly PressPac -- May 28, 2008 6American Chemical Society's Weekly PressPac -- May 28, 2008 7Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research 2Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research 3New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 2New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 3New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 4
... solid. PROTECT FROM LIGHT. PACKAGED UNDER ... that acts as a selective, reversible ... (IC 50 = 4 μM ... and PTP1B 298 , respectively). ...
...
BD Falcon microtest assay plate. 1536 well 12l, black BD Optilux PS. Polystyrene, nonsterile, no lid (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
... immunowash microplate washer 100-240 V, is used ... U-, or V-bottom wells. The immunowash microplate ... needle positions to an accuracy of 0.1 ... overflow washing. It can store up to ...
Biology Products: